Daewon Pharmaceutical Co., Ltd.
Clinical trials sponsored by Daewon Pharmaceutical Co., Ltd., explained in plain language.
-
New drug DW4421 put through interaction test with common antibiotics
Knowledge-focused Not yet recruitingThis early-stage trial will test how a new drug called DW4421 interacts with two common antibiotics (amoxicillin and clarithromycin) in 36 healthy adults aged 19 to 50. The study measures safety and how the drug levels change when taken together. It does not aim to treat any dise…
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 23, 2026 12:08 UTC
-
New drug DW5524 tested in healthy people for first time
Knowledge-focused Not yet recruitingThis early-phase trial will test the safety and how the body handles a single dose of DW5524 in 48 healthy adults. Participants will be randomly assigned to receive either DW5524 or a related version, DW5524-A. The study aims to understand the drug's effects and how it moves thro…
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:59 UTC
-
Healthy volunteers needed to test two new drug formulations in Early-Stage trial
Knowledge-focused Not yet recruitingThis early-stage study tests two experimental drugs (DW4421-T1 and DW4421S-T1) in 38 healthy adults aged 19 to 50. The goal is to check how safe they are and how the body processes them. Participants will receive a single dose of each drug in a random order and be monitored close…
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC